hallo iedereen: ik wil praten Over CBD want het helpt me te veel 1 om mijn haar te laten groeien en mijn bed comfortabeler en meer te maken Je kunt het haar controleren : https://bit.ly/2UscLEN
There is no research, lololol https://www.ncbi.nlm.nih.gov/pubmed/28588483 Front Pharmacol. 2017 May 23;8:269. doi: 10.3389/fphar.2017.00269. eCollection 2017 Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders. Campos AC1, Fogaça MV1, Scarante FF1, Joca SRL2, Sales AJ2, Gomes FV3, Sonego AB1, Rodrigues NS1, Galve-Roperh I4,5, Guimarães FS1.
Beneficial effects of cannabidiol (CBD) have been described for a wide range of psychiatric disorders, including anxiety, psychosis, and depression. The mechanisms responsible for these effects, however, are still poorly understood. Similar to clinical antidepressant or atypical antipsychotic drugs, recent findings clearly indicate that CBD, either acutely or repeatedly administered, induces plastic changes. For example, CBD attenuates the decrease in hippocampal neurogenesis and dendrite spines density induced by chronic stress and prevents microglia activation and the decrease in the number of parvalbumin-positive GABA neurons in a pharmacological model of schizophrenia.
More recently, it was found that CBD modulates cell fate regulatory pathways such as autophagy and others critical pathways for neuronal survival in neurodegenerative experimental models, suggesting the potential benefit of CBD treatment for psychiatric/cognitive symptoms associated with neurodegeneration. These changes and their possible association with CBD beneficial effects in psychiatric disorders are reviewed here.
Front Pharmacol. 2017 Feb 3;8:20. doi: 10.3389/fphar.2017.00020. ECollection 2017
In Vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease. Watt G1, Karl T2
Alzheimer's disease (AD) is a debilitating neurodegenerative disease that is affecting an increasing number of people. It is characterized by the accumulation of amyloid-β and tau hyperphosphorylation as well as neuroinflammation and oxidative stress. Current AD treatments do not stop or reverse the disease progression, highlighting the need for new, more effective therapeutics. Cannabidiol (CBD) is a non-psychoactive phytocannabinoid that has demonstrated neuroprotective, anti-inflammatory and antioxidant properties in vitro. Thus, it is investigated as a potential multifunctional treatment option for AD. Here, we summarize the current status quo of in vivo effects of CBD in established pharmacological and transgenic animal models for AD.
The studies demonstrate the ability of CBD to reduce reactive gliosis and the neuroinflammatory response as well as to promote neurogenesis. Importantly, CBD also reverses and prevents the development of cognitive deficits in AD rodent models. Interestingly, combination therapies of CBD and Δ9-tetrahydrocannabinol (THC), the main active ingredient of cannabis sativa, show that CBD can antagonize the psychoactive effects associated with THC and possibly mediate greater therapeutic benefits than either phytocannabinoid alone. The studies provide "proof of principle" that CBD and possibly CBD-THC combinations are valid candidates for novel AD therapies. Further investigations should address the long-term potential of CBD and evaluate mechanisms involved in the therapeutic effects described.
I'm not interested in getting high. But it appears that CBD is turning out to be a fantastic alternative to the pathetic and deadly and corrupt products of the medical establishment, for treating chronic pain. Conventional pharmaceuticals have failed utterly, obviously, except for producing substances meant to ease the suffering of the terminally ill.
"A small shop, not a big shop" Can we get a triple-digit IQ on the desk here?
Even if it's a fad (it's not) it will grow but why 100 products? Doesn't that create consumer fatigue? In at 2.05
Only idiots buy and use cbd…grow your own.its very easy.plus chronic pain does nothing…..
Ticker GGBXF . Invest now for the furniture.great brand great management.
Male co anchor is a stooge.
CBD doesn't just come from Hemp. It comes from marijuana. The stuff from Hemp is less potent and less effective in my experience.
"Skin Care" products are overpriced.
hallo iedereen: ik wil praten Over CBD want het helpt me te veel 1 om mijn haar te laten groeien en mijn bed comfortabeler en meer te maken Je kunt het haar controleren : https://bit.ly/2UscLEN
There is no research, lololol https://www.ncbi.nlm.nih.gov/pubmed/28588483
Front Pharmacol. 2017 May 23;8:269. doi: 10.3389/fphar.2017.00269. eCollection 2017
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders. Campos AC1, Fogaça MV1, Scarante FF1, Joca SRL2, Sales AJ2, Gomes FV3, Sonego AB1, Rodrigues NS1, Galve-Roperh I4,5, Guimarães FS1.
Beneficial effects of cannabidiol (CBD) have been described for a wide range of psychiatric disorders, including anxiety, psychosis, and depression. The mechanisms responsible for these effects, however, are still poorly understood. Similar to clinical antidepressant or atypical antipsychotic drugs, recent findings clearly indicate that CBD, either acutely or repeatedly administered, induces plastic changes. For example, CBD attenuates the decrease in hippocampal neurogenesis and dendrite spines density induced by chronic stress and prevents microglia activation and the decrease in the number of parvalbumin-positive GABA neurons in a pharmacological model of schizophrenia.
More recently, it was found that CBD modulates cell fate regulatory pathways such as autophagy and others critical pathways for neuronal survival in neurodegenerative experimental models, suggesting the potential benefit of CBD treatment for psychiatric/cognitive symptoms associated with neurodegeneration. These changes and their possible association with CBD beneficial effects in psychiatric disorders are reviewed here.
https://www.ncbi.nlm.nih.gov/pubmed/28217094
Front Pharmacol. 2017 Feb 3;8:20. doi: 10.3389/fphar.2017.00020. ECollection 2017
In Vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease. Watt G1, Karl T2
Alzheimer's disease (AD) is a debilitating neurodegenerative disease that is affecting an increasing number of people. It is characterized by the accumulation of amyloid-β and tau hyperphosphorylation as well as neuroinflammation and oxidative stress. Current AD treatments do not stop or reverse the disease progression, highlighting the need for new, more effective therapeutics. Cannabidiol (CBD) is a non-psychoactive phytocannabinoid that has demonstrated neuroprotective, anti-inflammatory and antioxidant properties in vitro. Thus, it is investigated as a potential multifunctional treatment option for AD. Here, we summarize the current status quo of in vivo effects of CBD in established pharmacological and transgenic animal models for AD.
The studies demonstrate the ability of CBD to reduce reactive gliosis and the neuroinflammatory response as well as to promote neurogenesis. Importantly, CBD also reverses and prevents the development of cognitive deficits in AD rodent models. Interestingly, combination therapies of CBD and Δ9-tetrahydrocannabinol (THC), the main active ingredient of cannabis sativa, show that CBD can antagonize the psychoactive effects associated with THC and possibly mediate greater therapeutic benefits than either phytocannabinoid alone. The studies provide "proof of principle" that CBD and possibly CBD-THC combinations are valid candidates for novel AD therapies. Further investigations should address the long-term potential of CBD and evaluate mechanisms involved in the therapeutic effects described.
Learn.
https://youtu.be/H3EP2nV_6Cc Medical Cannabis, The Herb and Its Applications This talk will be presented by Judy Mikovitz PhD
https://youtu.be/AWuM8SQ9aU0
The Re-Discovery of the Benefits of Medicinal Cannabis – Dr. John Hicks
https://youtu.be/3sEwoJv_NRc
Understanding the Endocannabinoid System, National Institutes of Health
https://youtu.be/sBWfFm5ebpE
Clinical Application of Cannabinoids and Terpenes | M. Gordon, Cannafest 2015
https://youtu.be/YR8A0lskwTY
The Endocannabinoid System, Patients out of Time: Mary Lynne Mathre, Part 1 of 5.
https://youtu.be/RIlo2KsILv8
CBDTV Reel 1 Doctors and Diabetes Testimonies
https://youtu.be/3bZb10ZxpBk
The Inside Story of Cannabidiol – What Are the Benefits of CBD?
https://youtu.be/7Ua9Q0fEN1s
Dr. Stuart Titus, CBD and medical research
https://youtu.be/vEPZDR1Bdts
Dr. Blair on CBD for PTSD
https://youtu.be/HBEhYQY1i-E
Dr. Donald Abrams on anxiety, depression and PTSD
https://youtu.be/TTeagW1XONI
David Bearman M.D. Cannabis, cannabinoids, ADHD/ADD, Tourette's Syndrome, Migraine Headaches, Bi-Polar disorder
https://youtu.be/2x7S9nVUkBo
CBD is great for anxiety – Dr. Hicks
https://youtu.be/9m9_OHq3vqA
No more anxiety meds with CBD
https://youtu.be/I9z0bqLEEu4
Dr. John Hicks, cannabidiol from hemp
https://youtu.be/LCs4B-oXOdk
Dr. David Allen the discovery of the endocannabinoid system
https://youtu.be/n3fkiwTABag
Dr. Ralph Mechoulam on the endocannabinoid system
https://youtu.be/fGzG3-Mtmxk
The Endocannabinoid system in health and disease, Dr. Ethan Russo Part 1
https://youtu.be/xdW_Vbcbwl0
The Endocannabinoid system in health and disease, Dr. Ethan Russo Part 2
https://youtu.be/3SA82u3XGlM
Dr. Michelle Weiner How your endocannabinoid system works to treat patients Canna Ed Day 2017
https://youtu.be/rhZMPcLflNo
The Endocannabinoid System (ECS) Treatment Implications in ASD – Tracy Fritz, MD
https://youtu.be/TmT4cDuDj7s
Cannabis and Gut Health: Medical Marijuana Science
https://youtu.be/hRxh3wF082Y
Endocannabinoid System Part 1
https://youtu.be/RGGIveFYvQI
Does medical marijuana relieve back pain Dr. Rachna Patel
https://youtu.be/-xyMTmTpojQ
Benefits of CBD Cannabidiol : Delivery systems, usage and mechanism in neuroinflammatory disorders.
https://youtu.be/-jjlokqg6Sg
Dr. Lumir Hanus – Why is Cannabis Such a Successful Medicine
https://youtu.be/yZzMLVRbgIQ
Cannabis Against Cancer Dr. Christina Sanchez PhD., Mara Gordon, Dr. Dennis Landaverde, Andrea Cartin MD
https://youtu.be/MjxfeEEhr_U
Dr. Blair on inflammation and CBD
https://youtu.be/Z-OEpwgv6aM
Cannabasics The Endocannabinoid System, Nyishar
https://youtu.be/2ukz7YfStkI
Cannabidiol Science : For Doctors : For Patients Americans for Safe Access
https://youtu.be/Qp6dS4I-zpk Answers to FAQ about Medical Marijuana Dr. Scott Schwartzwelder
I'm not interested in getting high. But it appears that CBD is turning out to be a fantastic alternative to the pathetic and deadly and corrupt products of the medical establishment, for treating chronic pain. Conventional pharmaceuticals have failed utterly, obviously, except for producing substances meant to ease the suffering of the terminally ill.
Sick of seeing “CBD” signs everywhere